Related references
Note: Only part of the references are listed.Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV
Emma C. Thomson et al.
AIDS (2009)
Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size
N. Craine et al.
EPIDEMIOLOGY AND INFECTION (2009)
Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action
Mathew Hickman et al.
JOURNAL OF PUBLIC HEALTH (2009)
An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales
D. De Angelis et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2009)
Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial
M. Hickman et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates
Kimberly Page-Shafer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand
Wantanee Wattana et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004
M. Hickman et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users
Charlotte Van den Berg et al.
ADDICTION (2007)
Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients
Ricky N. Bluthenthal et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study
P. Vickerman et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2007)
High hepatitis C incidence in new injecting drug users: a policy failure?
Lisa Maher et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2007)
Developing an HIV Behavioral Surveillance System for injecting drug users: The National HIV Behavioral Surveillance System
Amy Lansky et al.
PUBLIC HEALTH REPORTS (2007)
Methods to recruit hard-to-reach groups: Comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia
Lucy Platt et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2006)
Respondent-driven sampling of injection drug users in two US-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence
Simon D. W. Frost et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2006)
Implementation and analysis of respondent driven sampling: Lessons learned from the field
Abu S. Abdul-Quader et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2006)
Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia
Lisa Maher et al.
ADDICTION (2006)
Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users
Peter Vickerman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Effectiveness of respondent-driven sampling for recruiting drug users in New York city: Findings from a pilot study
Abu S. Abdul-Quader et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2006)
Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence
Alex Wodak et al.
SUBSTANCE USE & MISUSE (2006)
Prolonged time until seroconversion among hemodialysis patients: the need for HCVPCR
M Schroeter et al.
INTERVIROLOGY (2005)
Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study
A Judd et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Hepatitis C virus infection among injection drug users - Survival analysis of time to seroconversion
H Hagan et al.
EPIDEMIOLOGY (2004)
Failure to diagnose recent hepatitis C virus infections in London injecting drug users
E Aarons et al.
JOURNAL OF MEDICAL VIROLOGY (2004)
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots
A Judd et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
DC Des Jarlais et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment
LE Thorpe et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations
DD Heckathorn
SOCIAL PROBLEMS (2002)
Treatment of acute hepatitis C with interferon alfa-2b
E Jaeckel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98
KM Roy et al.
JOURNAL OF INFECTION (2001)
Share Paper
